Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
January 30, 2024	8-K	Report of unscheduled material events or corporate event	0001517022-24-000014.pdf 0001517022-24-000014.rtf 0001517022-24-000014.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
February 13, 2024	8-K	Report of unscheduled material events or corporate event	0001517022-24-000019.pdf 0001517022-24-000019.rtf 0001517022-24-000019.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
March 14, 2024	8-K	Report of unscheduled material events or corporate event	0001517022-24-000029.pdf 0001517022-24-000029.rtf 0001517022-24-000029.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
March 15, 2024	8-K	Report of unscheduled material events or corporate event	0001193125-24-069123.pdf 0001193125-24-069123.rtf 0001193125-24-069123.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
March 28, 2024	8-K	Report of unscheduled material events or corporate event	0001517022-24-000031.pdf 0001517022-24-000031.rtf 0001517022-24-000031.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
April 16, 2024	8-K	Report of unscheduled material events or corporate event	0001517022-24-000033.pdf 0001517022-24-000033.rtf 0001517022-24-000033.xls View HTML
April 23, 2024	8-K	Report of unscheduled material events or corporate event	0001517022-24-000035.pdf 0001517022-24-000035.rtf 0001517022-24-000035.xls View HTML
September 22, 2014	8-K/A	Amendment to a previously filed 8-K	0001193125-14-348625.pdf 0001193125-14-348625.rtf 0001193125-14-348625.xls View HTML
September 22, 2014	8-K/A	Amendment to a previously filed 8-K	0001193125-14-348637.pdf 0001193125-14-348637.rtf 0001193125-14-348637.xls View HTML
December 14, 2016	8-K/A	Amendment to a previously filed 8-K	0001193125-16-792963.pdf 0001193125-16-792963.rtf 0001193125-16-792963.xls View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax